Wermer Syndrome (MEN Type 1) Multiple endocrine neoplasia

1 Views
administrator
administrator
07/10/23

๐Ÿ“Œ ๐…๐จ๐ฅ๐ฅ๐จ๐ฐ ๐จ๐ง ๐ˆ๐ง๐ฌ๐ญ๐š๐ ๐ซ๐š๐ฆ:- https://www.instagram.com/drgbhanuprakash
๐Ÿ“Œ๐—๐—ผ๐—ถ๐—ป ๐—ข๐˜‚๐—ฟ ๐—ง๐—ฒ๐—น๐—ฒ๐—ด๐—ฟ๐—ฎ๐—บ ๐—–๐—ต๐—ฎ๐—ป๐—ป๐—ฒ๐—น ๐—›๐—ฒ๐—ฟ๐—ฒ:- https://t.me/bhanuprakashdr
๐Ÿ“Œ๐—ฆ๐˜‚๐—ฏ๐˜€๐—ฐ๐—ฟ๐—ถ๐—ฏ๐—ฒ ๐—ง๐—ผ ๐— ๐˜† ๐— ๐—ฎ๐—ถ๐—น๐—ถ๐—ป๐—ด ๐—Ÿ๐—ถ๐˜€๐˜:- https://linktr.ee/DrGBhanuprakash

Wermer Syndrome (MEN Type 1) Multiple endocrine neoplasia

Multiple endocrine neoplasia (MEN) syndromes consist of 2 categories, MEN type 1 (MEN1) and MEN type 2 (MEN2). MEN2 has been subcategorized into MEN2-A, MEN2-B, and medullary thyroid cancer (MTC)โ€“only.
The combination of parathyroid tumors, pancreatic islet cell tumors, and anterior pituitary tumors (see the images below) is characteristic of MEN1. Although usually inherited as an autosomal dominant disorder, MEN1 can also occur sporadically (without a family history) as a result of new mutations. It is also important to keep in mind that family members of an MEN1-affected individual may have been undiagnosed at the time of death. Patients with untreated MEN1 have a decreased life expectancy, with a 50% probability of death by age 50 years.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next